| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | -0.21 | 0.2 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.14 | 0.2 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.076 | 0.2 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |